Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Uniqure N.V.. (2/15/16). "Press Release: Uniqure to Present at the RBC Capital Markets 2016 Global Healthcare Conference". Amsterdam.

Organisations Organisation Uniqure N.V. (Nasdaq: QURE)
  Group Uniqure (Group)
  Organisation 2 RBC Capital Markets, LLC
Products Product RBC Capital Markets Global Healthcare Conference 2016 New York
  Product 2 gene therapy
Index term Index term Uniqure–RBC Capital Markets: investor conference, 201602 supply service Uniqure presents at RBC Capital Markets Global Healthcare Conference
Persons Person Soland, Daniel (Dan) (Uniqure 201512–201609 CEO before ViroPharma + Chiron Vaccines + Epigenesis RESIGNED 9/16)
  Person 2 Schweitzer, Gretchen (MacDougall 201307 European Office)
     


uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, announced today that Dan Soland, Chief Executive Officer, will present at the RBC Capital Markets 2016 Global Healthcare Conference on February 24, 2016 at 2:05 p.m. EST / 20:05 p.m. CET. The conference is being held February 23 – 24, 2016 at The Palace Hotel in New York City.

The webcast, including a slide presentation, can be accessed through the following link: http://www.veracast.com/webcasts/rbc/healthcare2016/26211430508.cfm or by accessing the link displayed in the “Events” section on the “Media” page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.


About uniQure

uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com


uniQure:
Eva Mulder
Direct : +31 20 240 6103
Main: +31 20 240 6000
e.mulder@uniQure.com

Media inquiries:
Gretchen Schweitzer
MacDougall Biomedical Communications
Direct: +49 172 861 8540
Main: +49 89 2424 3494 or +1 781 235 3060
gschweitzer@macbiocom.com

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Uniqure (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px